NASDAQ:CLVS
$0.151
(
0%
)
Friday, 27th Jan 2023
Clovis Oncology Stock Price (Quote)
| Range | Low Price | High Price | Comment |
|---|---|---|---|
| 30 days | $0.0471 | $0.189 | Friday, 27th Jan 2023 CLVS stock ended at $0.151. During the day the stock fluctuated 0% from a day low at $0.151 to a day high of $0.151. |
| 90 days | $0.0471 | $1.11 | |
| 52 weeks | $0.0471 | $3.25 |
Historical Clovis Oncology prices
| Date | Open | High | Low | Close | Volume |
| 2023-01-27 | $0.151 | $0.151 | $0.151 | $0.151 | 0 |
| 2023-01-26 | $0.151 | $0.151 | $0.151 | $0.151 | 0 |
| 2023-01-25 | $0.151 | $0.151 | $0.151 | $0.151 | 0 |
| 2023-01-24 | $0.151 | $0.151 | $0.151 | $0.151 | 0 |
| 2023-01-23 | $0.151 | $0.151 | $0.151 | $0.151 | 0 |
| 2023-01-20 | $0.141 | $0.160 | $0.141 | $0.151 | 396 831 |
| 2023-01-19 | $0.145 | $0.168 | $0.120 | $0.150 | 1 320 433 |
| 2023-01-18 | $0.133 | $0.153 | $0.133 | $0.145 | 1 341 577 |
| 2023-01-17 | $0.130 | $0.150 | $0.0923 | $0.133 | 5 017 076 |
| 2023-01-13 | $0.144 | $0.159 | $0.141 | $0.153 | 1 590 512 |
| 2023-01-12 | $0.110 | $0.160 | $0.106 | $0.156 | 3 013 074 |
| 2023-01-11 | $0.0712 | $0.189 | $0.0712 | $0.120 | 5 439 551 |
| 2023-01-10 | $0.0505 | $0.0790 | $0.0500 | $0.0740 | 1 173 691 |
| 2023-01-09 | $0.0496 | $0.0650 | $0.0471 | $0.0600 | 957 846 |
| 2023-01-06 | $0.0491 | $0.0530 | $0.0487 | $0.0496 | 498 141 |
| 2023-01-05 | $0.0783 | $0.0783 | $0.0783 | $0.0783 | 0 |
| 2023-01-04 | $0.0783 | $0.0783 | $0.0783 | $0.0783 | 0 |
| 2023-01-03 | $0.0783 | $0.0783 | $0.0783 | $0.0783 | 0 |
| 2022-12-30 | $0.0783 | $0.0783 | $0.0783 | $0.0783 | 0 |
| 2022-12-29 | $0.0783 | $0.0783 | $0.0783 | $0.0783 | 0 |
| 2022-12-28 | $0.0783 | $0.0783 | $0.0783 | $0.0783 | 0 |
| 2022-12-27 | $0.0783 | $0.0783 | $0.0783 | $0.0783 | 0 |
| 2022-12-23 | $0.0783 | $0.0783 | $0.0783 | $0.0783 | 0 |
| 2022-12-22 | $0.0783 | $0.0783 | $0.0783 | $0.0783 | 0 |
| 2022-12-21 | $0.0783 | $0.0783 | $0.0783 | $0.0783 | 0 |
| 2022-12-20 | $0.0808 | $0.0977 | $0.0766 | $0.0812 | 24 516 461 |
| 2022-12-19 | $0.0800 | $0.0920 | $0.0770 | $0.0860 | 19 780 678 |
| 2022-12-16 | $0.0952 | $0.110 | $0.0760 | $0.0800 | 22 992 778 |
| 2022-12-15 | $0.108 | $0.108 | $0.0920 | $0.0982 | 15 671 146 |
| 2022-12-14 | $0.140 | $0.144 | $0.103 | $0.106 | 24 439 580 |
| 2022-12-13 | $0.185 | $0.197 | $0.125 | $0.133 | 18 726 421 |
| 2022-12-12 | $0.206 | $0.275 | $0.172 | $0.202 | 28 327 640 |
| 2022-12-09 | $0.222 | $0.229 | $0.200 | $0.200 | 2 435 764 |
| 2022-12-08 | $0.216 | $0.239 | $0.202 | $0.222 | 4 019 124 |
| 2022-12-07 | $0.240 | $0.250 | $0.223 | $0.223 | 2 693 680 |
| 2022-12-06 | $0.280 | $0.291 | $0.237 | $0.252 | 4 719 040 |
| 2022-12-05 | $0.310 | $0.324 | $0.290 | $0.292 | 4 457 083 |
| 2022-12-02 | $0.350 | $0.360 | $0.333 | $0.344 | 2 682 279 |
| 2022-12-01 | $0.330 | $0.377 | $0.320 | $0.360 | 2 541 244 |
| 2022-11-30 | $0.320 | $0.350 | $0.317 | $0.330 | 1 698 950 |
| 2022-11-29 | $0.340 | $0.343 | $0.310 | $0.314 | 1 998 737 |
| 2022-11-28 | $0.336 | $0.355 | $0.323 | $0.340 | 2 075 150 |
| 2022-11-25 | $0.332 | $0.350 | $0.321 | $0.346 | 926 093 |
| 2022-11-23 | $0.343 | $0.355 | $0.330 | $0.340 | 2 325 544 |
| 2022-11-22 | $0.340 | $0.360 | $0.330 | $0.332 | 1 643 724 |
| 2022-11-21 | $0.357 | $0.364 | $0.340 | $0.344 | 1 408 788 |
| 2022-11-18 | $0.343 | $0.367 | $0.330 | $0.352 | 1 253 020 |
| 2022-11-17 | $0.333 | $0.375 | $0.317 | $0.368 | 2 244 380 |
| 2022-11-16 | $0.370 | $0.385 | $0.340 | $0.350 | 3 414 485 |
| 2022-11-15 | $0.400 | $0.470 | $0.362 | $0.382 | 9 237 797 |
About Clovis Oncology
Clovis Oncology, Inc., a biopharmaceutical company, focuses on acquiring, developing, and commercializing anti-cancer agents in the United States, Europe, and internationally. In the U.S., the company offers Rubraca (rucaparib), an oral small molecule inhibitor of poly ADP-ribose polymerase for recurrent epithelial ovarian, fallopian tube, or primary peritoneal cancer, as well as for metastatic castration-resistant prostate cancer. In Europe, the... CLVS Profile
Top Fintech Company
featured in The Global Fintech Index 2020 as the top Fintech company of the country.
